Søren Hardt‐Lindberg

2.6k total citations · 2 hit papers
9 papers, 1.5k citations indexed

About

Søren Hardt‐Lindberg is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Søren Hardt‐Lindberg has authored 9 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Søren Hardt‐Lindberg's work include Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pharmacology and Obesity Treatment (3 papers). Søren Hardt‐Lindberg is often cited by papers focused on Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pharmacology and Obesity Treatment (3 papers). Søren Hardt‐Lindberg collaborates with scholars based in United States, United Kingdom and Denmark. Søren Hardt‐Lindberg's co-authors include Helen M. Colhoun, A. Michael Lincoff, Donna H. Ryan, John Deanfield, Ildiko Lingvay, Steven E. Kahn, G. Kees Hovingh, Jorge Plutzky, Kirstine Brown‐Frandsen and Sille Esbjerg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American College of Cardiology.

In The Last Decade

Søren Hardt‐Lindberg

9 papers receiving 1.5k citations

Hit Papers

Semaglutide and Cardiovascular Outcomes in Obesity withou... 2023 2026 2024 2025 2023 2024 400 800 1.2k

Peers

Søren Hardt‐Lindberg
Comparison fields: 5 of 75
  • Endocrinology, Diabetes and Metabolism 1.0k
  • Pharmacology 473
  • Cardiology and Cardiovascular Medicine 366
  • Physiology 340
  • Surgery 328
Replace Kirstine Brown‐Frandsen with:
Kirstine Brown‐Frandsen United States
Sille Esbjerg Denmark
Tuğçe Kalaycı Oral United States
Robert F. Kushner United States
Frank Vercruysse United States
Emily Brown United Kingdom
Mark Warren United States
Dimitris Papamargaritis United Kingdom
Katelyn Brown United States
Nanna L. Lausvig Denmark
Kirstine Brown‐Frandsen United States View profile →
Citations per field, relative to Søren Hardt‐Lindberg
Søren Hardt‐Lindberg · 1×
Citations per year, relative to Søren Hardt‐Lindberg
Søren Hardt‐Lindberg · 1×

Countries citing papers authored by Søren Hardt‐Lindberg

Since Specialization
Citations

This map shows the geographic impact of Søren Hardt‐Lindberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Søren Hardt‐Lindberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Søren Hardt‐Lindberg more than expected).

Fields of papers citing papers by Søren Hardt‐Lindberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Søren Hardt‐Lindberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Søren Hardt‐Lindberg. The network helps show where Søren Hardt‐Lindberg may publish in the future.

Co-authorship network of co-authors of Søren Hardt‐Lindberg

This figure shows the co-authorship network connecting the top 25 collaborators of Søren Hardt‐Lindberg. A scholar is included among the top collaborators of Søren Hardt‐Lindberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Søren Hardt‐Lindberg. Søren Hardt‐Lindberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 22
2 1
3 26
4 1
5 1
6
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial breakdown →
100
7 5
8
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes breakdown →
1260
9 71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026